» Articles » PMID: 10849920

The Benefits of a Hospital Based Community Services Liaison Pharmacist

Overview
Journal Pharm World Sci
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2000 Jun 13
PMID 10849920
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the benefits of a community services liaison pharmacist in addressing medication misuse in elderly patients, which occur on both admission and discharge.

Design: Completion of a medication history for each patient on admission by the community liaison pharmacist. On discharge updated medication record sheets were faxed to the patient's GP and community pharmacy; a survey of GPs' and community pharmacists' opinions who were involved in the study was carried out.

Subjects And Setting: 109 patients over the age of 60 on 4 or more medications admitted by the medical admissions unit of Antrim Area Hospital.

Main Outcome Measures: Medication related problems; GP and community pharmacist opinions of the service.

Results: Of the 109 patients, 61% had an incomplete medication history on admission, 21% of patients who brought their own drugs were not dealt with appropriately in hospital and 33% of discharged patients had medication-related problems. The service was felt to be very useful by GPs (80%) and community pharmacists (100%). A reduction in readmission rate of 2.4% was seen in these patients compared to the average for this age group.

Conclusion: The community services liaison pharmacist produced benefits in terms of patient medication management, reduced readmission rates and wastage of patients' own drugs. A more detailed one-year study will now be carried out.

Citing Articles

Impact of a Medication Reconciliation Improvement Package on Adherence to Medication Reconciliation Among Internal Medicine Physicians: A Quality Improvement Project in a Lower-Middle Income Country.

Mahmood S, Rehman F, Jamal A, Meghani N, Iqbal M, Amirali A Hosp Pharm. 2024; 59(6):624-630.

PMID: 39449857 PMC: 11497527. DOI: 10.1177/00185787241253442.


The effect of a pharmaceutical transitional care program on rehospitalisations in internal medicine patients: an interrupted-time-series study.

Karapinar-Carkit F, Borgsteede S, Janssen M, Mak M, Yildirim N, Siegert C BMC Health Serv Res. 2019; 19(1):717.

PMID: 31638992 PMC: 6805673. DOI: 10.1186/s12913-019-4617-9.


Hospitalization Drug Regimen Changes in Geriatric Patients and Adherence to Modifications by General Practitioners in Primary Care.

Rouch L, Farbos F, Cool C, McCambridge C, Hein C, Elmalem S J Nutr Health Aging. 2018; 22(3):328-334.

PMID: 29484345 DOI: 10.1007/s12603-017-0940-1.


Hospital discharge: What are the problems, information needs and objectives of community pharmacists? A mixed method approach.

Bruhwiler L, Hersberger K, Lutters M Pharm Pract (Granada). 2017; 15(3):1046.

PMID: 28943987 PMC: 5597803. DOI: 10.18549/PharmPract.2017.03.1046.


Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital.

Karapinar-Carkit F, van der Knaap R, Bouhannouch F, Borgsteede S, Janssen M, Siegert C PLoS One. 2017; 12(4):e0174513.

PMID: 28445474 PMC: 5406030. DOI: 10.1371/journal.pone.0174513.